Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine vs Morphine for Neonatal Abstinence Syndrome
NCT03092011Phase 4Active, not recruiting
- Sponsor
- Cooper University Health Care
- Start
- Feb 2018
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clonidine in neonatal abstinence syndrome (NAS), sponsored by Cooper University Health Care. Started Feb 2018; status: active, not recruiting.
02
Drugs
clonidine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT03092011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092011.